Pacific Biosciences of California, Inc.
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.77 USD | +2.91% | -3.28% | -81.96% |
09/05 | Transcript : Pacific Biosciences of California, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q1 Revenue $38.8M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.96% | 482M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- PACB Stock
- News Pacific Biosciences of California, Inc.
- UBS Lifts Price Target on Pacific Biosciences of California to $12.50 From $10, Keeps Buy Rating